Sleep Quantity and Quality in the ICU: a Prospective Observational Stud

July 21, 2022 updated by: Gianluca Villa, Careggi Hospital

Sleep Quantity and Quality in the ICU: a Prospective Observational Study

Several evidences in the literature suggest sleep interruption in critical care patients. Nowadays, the amount and the quality of sleep phases during the length of stay in the intensive care unit are largely unknown.

In this study, the amount of time spent by the patients in N1, N2 N3 and REM phases during sleep is quantified.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

72

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Florence, Italy, 50100
        • Azienda Ospedaliero Universitaria Careggi

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Critically ill patients

Description

Inclusion Criteria:

  • age > 18 years

Exclusion Criteria:

  • Pregnancy
  • Previous enrollment in the same study (sleep recording during previous night)
  • Previous use of hypnotic drugs

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Critically ill patients
age > 18 years
Patients are observed through a Sleep profiler, routinely used in the intensive care unit (ICU). This device is applied at every patient in the ICU and it acquires EEG, electrooculography, and electromyography from three frontopolar EEG signals.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sleep N2 phase
Time Frame: The sleep architecture will be observed during the first night spent in the ICU
describe the percentage of the total sleep time spent by the patient in N2 stage
The sleep architecture will be observed during the first night spent in the ICU

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sleep N1 phase
Time Frame: The sleep architecture will be observed during the first night spent in the ICU
describe the percentage of the total sleep time spent by the patient in N1 stage
The sleep architecture will be observed during the first night spent in the ICU
Sleep N3 phase
Time Frame: The sleep architecture will be observed during the first night spent in the ICU
describe the percentage of the total sleep time spent by the patient in N3 stage
The sleep architecture will be observed during the first night spent in the ICU
Sleep REM phase
Time Frame: The sleep architecture will be observed during the first night spent in the ICU
describe the percentage of the total sleep time spent by the patient in REM stage
The sleep architecture will be observed during the first night spent in the ICU

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Gianluca Villa, MD, Azienda Careggi

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2018

Primary Completion (Actual)

January 31, 2019

Study Completion (Actual)

March 31, 2019

Study Registration Dates

First Submitted

January 4, 2019

First Submitted That Met QC Criteria

January 6, 2019

First Posted (Actual)

January 8, 2019

Study Record Updates

Last Update Posted (Actual)

July 22, 2022

Last Update Submitted That Met QC Criteria

July 21, 2022

Last Verified

July 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Critical Illness

Clinical Trials on Sleep Profiler

3
Subscribe